A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of Mevrometostat (PF-06821497) with Enzalutamide in Metastatic Castration-Sensitive Prostate Cancer
-
Enrollment
This study is currently enrolling. -
Associated Conditions
-
Research Area
Clinical Cancer Research -
Location
-
Principal Investigator
Lawrence Karsh -
Sponsor
Pfizer Inc
Enrollment Form
This study is currently enrolling.
